The efficacy of a 7-day switch therapy with parenteral cefuroxime in a dose of 750 mg for 3-5 days followed by the use of oral cefuroxime axetil in a dose of 500 mg every 12 hours was compared with that of a 7-day therapy with parenteral cefuroxime in a dose of 750 mg every 8 hours in hospitalized patients with community-acquired pneumonia. The clinical and bacteriological efficacies and pharmacokinetic properties of both the dosage forms were estimated. It was shown that the clinical and bacteriological effects did not significantly differ in the patients under the parenteral regimen with cefuroxime and under the parenteral-to-oral regimen with cefuroxime and cefuroxime axetil: the cure in 75 and 83 per cent of the patients and the bacteriological response in 100 and 86 per cent of the cases respectively. The results indicated that the cost of the switch therapy was much lower while the efficacy did not decrease.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cefuroxime axetil
12
community-acquired pneumonia
8
cefuroxime
8
cefuroxime cefuroxime
8
switch therapy
8
therapy parenteral
8
parenteral cefuroxime
8
cefuroxime dose
8
dose 750
8
clinical bacteriological
8

Similar Publications

Long-term forecast for antibacterial drug consumption in Germany using ARIMA models.

Naunyn Schmiedebergs Arch Pharmacol

January 2025

Hannover Medical School, Institute of Pharmacology, D-30625, Hannover, Germany.

Article Synopsis
  • This study forecasts the consumption of the top ten antibacterial drugs in Germany until 2040, using historical prescription data and ARIMA models.
  • The best model for forecasting is a simple random walk with drift (ARIMA(0,1,0)), while short-term predictions show minimal variation among complex models.
  • Predictions indicate rising prescriptions for some drugs like amoxicillin, but declines for others, emphasizing the need for proactive healthcare planning to address potential shortages.
View Article and Find Full Text PDF

Antibiotic resistance in community-acquired urinary tract infections. Did the COVID-19 pandemic cause a change?

J Infect Dev Ctries

September 2024

Division of Allergy and Immunology, Department of Pediatrics; School of Medicine, University of Kyrenia, Kyrenia, Cyprus.

Article Synopsis
  • The study evaluated antimicrobial resistance rates in urine cultures before and during the COVID-19 pandemic, analyzing data from 897 patients over six years.
  • E. coli and K. pneumoniae were the primary bacteria identified, with increased resistance rates for antibiotics like cefixime and ceftriaxone during the pandemic.
  • Factors such as male gender and ESBL positivity were linked to higher resistance rates, indicating a notable increase in antibiotic resistance among uropathogens during this period.
View Article and Find Full Text PDF

Low oral bioavailability is a common feature in most drugs, including antibiotics, due to low solubility in physiological media and inadequate cell permeability, which may limit their efficacy or restrict their administration in a clinical setting. Cefuroxime is usually administered in its prodrug form, cefuroxime axetil. However, its preparation requires further reaction steps and additional metabolic pathways to be converted into its active form.

View Article and Find Full Text PDF

Rising bacterial resistance is a global threat, causing rising financial burdens on healthcare systems and endangering effective treatment of bacterial infections. To ensure the efficacy of antibacterial drugs, it is essential to identify the most dangerous pathogens and vulnerable antibacterial drugs. Previous research by our group suggested irrational outpatient prescribing practices in Germany, supporting a growing bacterial resistance.

View Article and Find Full Text PDF

Previous research from our group revealed a strong association between daily defined dose (DDD)-costs and -prescriptions of antibacterial drugs in Germany ( https://pubmed.ncbi.nlm.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!